AKT1 and neoplasm: It hampers tumour cell growth and proliferation via the impairment of intracellular mediators of, e.g., PI3K-AKT, ERK1 and ERK2, STAT3 and WNT-β-catenin signalling, leading to greater cell cycle arrest and apoptosis [169].